These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12928298)

  • 1. Photodynamic therapy for recurrent myopic choroidal neovascularisation after limited macular translocation surgery.
    Chan WM; Lam DS; Liu DT; Wong TH; Yuen KS
    Br J Ophthalmol; 2003 Sep; 87(9):1188-9. PubMed ID: 12928298
    [No Abstract]   [Full Text] [Related]  

  • 2. Choroidal neovascularisation in pathological myopia: an update in management.
    Chan WM; Ohji M; Lai TY; Liu DT; Tano Y; Lam DS
    Br J Ophthalmol; 2005 Nov; 89(11):1522-8. PubMed ID: 16234465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: a two-year study.
    Glacet-Bernard A; Benyelles N; Dumas S; Haddad WM; Voigt M; Razavi S; Roquet W; Coscas G; Soubrane G
    Am J Ophthalmol; 2007 Jan; 143(1):68-76. PubMed ID: 17188042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy.
    Schmidt JC; Mennel S; Hörle S; Meyer CH
    Br J Ophthalmol; 2006 Nov; 90(11):1361-2. PubMed ID: 16854830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia.
    Gibson J
    Eye (Lond); 2005 Aug; 19(8):829-30. PubMed ID: 16086038
    [No Abstract]   [Full Text] [Related]  

  • 6. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.
    Montero JA; Ruiz-Moreno JM
    Br J Ophthalmol; 2003 Feb; 87(2):173-6. PubMed ID: 12543746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes.
    Ruiz-Moreno JM; Montero JA
    Br J Ophthalmol; 2003 Jul; 87(7):856-9. PubMed ID: 12812885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre.
    Rishi P; Rishi E; Bhende M; Agarwal V; Vyas CH; Valiveti M; Bhende P; Rao C; Susvar P; Sen P; Raman R; Khetan V; Murali V; Ratra D; Sharma T
    Br J Ophthalmol; 2016 Oct; 100(10):1337-40. PubMed ID: 26792945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular relocation after photodynamic therapy for recurrent choroidal neovascular membrane: visual results and histopathological findings.
    Stanga P; Hiscott P; Li K; Wong D
    Br J Ophthalmol; 2003 Aug; 87(8):975-6. PubMed ID: 12881338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamic phototherapy with silicone oil in treating choroidal subfoveal neovascularization in high myopia].
    Soler V; Pagot-Mathis V; Quintyn JC
    J Fr Ophtalmol; 2011 Oct; 34(8):561.e1-4. PubMed ID: 21570149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.
    Parodi MB; Da Pozzo S; Ravalico G
    Br J Ophthalmol; 2003 Feb; 87(2):177-83. PubMed ID: 12543747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation.
    Varano M; Parisi V; Tedeschi M; Sciamanna M; Gallinaro G; Capaldo N; Catalano S; Pascarella A
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1453-62. PubMed ID: 15790915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year results of macular translocation with scleral infolding in myopic choroidal neovascularisation.
    Mateo C; Moreno J; Rosales G; Lechuga M; Castillo R; Vaz F; Corcóstegui B
    Semin Ophthalmol; 2004; 19(1-2):29-42. PubMed ID: 15590532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Choroidal changes after photodynamic therapy (PDT). A two-year follow-up study of 38 patients].
    Michels S; Barbazetto I; Schmidt-Erfurth U
    Klin Monbl Augenheilkd; 2000 Aug; 217(2):94-9. PubMed ID: 11022663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progression of choroidal neovascularization after macular translocation in age-related macular degeneration and degenerative myopia].
    Simon P; Glacet-Bernard A; Coscas G; Soubrane G
    J Fr Ophtalmol; 2002 Sep; 25(7):694-700. PubMed ID: 12399725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation--'beyond the TAP study'.
    Barnes RM; Gee L; Taylor S; Briggs MC; Harding SP
    Eye (Lond); 2004 Aug; 18(8):809-13. PubMed ID: 14963483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of photodynamic therapy in ophthalmology.
    Sivaprasad S; Hykin P
    Br J Hosp Med (Lond); 2006 Dec; 67(12):647-50. PubMed ID: 17328448
    [No Abstract]   [Full Text] [Related]  

  • 18. Limited macular translocation.
    de Juan E; Fujii GY
    Eye (Lond); 2001 Jun; 15(Pt 3):413-23. PubMed ID: 11450767
    [No Abstract]   [Full Text] [Related]  

  • 19. [Photodynamic therapy carefully destroys neovascularization of the retina].
    Ophthalmologe; 2003 Feb; 100(2):1 p following 174. PubMed ID: 12650171
    [No Abstract]   [Full Text] [Related]  

  • 20. Pigment epithelial changes in young women treated with photodynamic therapy and limited macular translocation for classic choroidal neovascularisation.
    Glacet-Bernard A; Coscas G; Soubrane G
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1373-6. PubMed ID: 16523298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.